Cancer pharmacogenomics: achievements in basic research
Cancer pharmacogenomics: achievements in basic research
复制标题
癌症药物基因组学:基础研究成果
DOI:
10.1007/s10147-004-0463-8
复制
发表时间:
2005
影响因子:
3.3
通讯作者:
T. Yokoi
中科院分区:
文献类型:
--
作者:
M. Nakajima;T. Yokoi
Pharmacogenomics is the study of how genetic inheritance influences the responses to drugs. Genetic polymorphisms in drug-metabolizing enzymes result in altered pharmacokinetics in therapeutic drugs. In recent years, there has been great progress in our knowledge of the effects of cytochrome P450 (CYP) polymorphisms on the pharmacokinetics of therapeutic drugs. CYP enzymes catalyze the activation or detoxification of several anticancer drugs. Anticancer drugs generally have a narrow therapeutic margin. Therefore, the interindividual variability in their efficacy and toxicity is a major problem in clinical practice. In this review, genetic polymorphisms of CYP enzymes and their clinical relevance in cancer chemotherapy are discussed.
登录
查看更多内容
DOI:
--
发表时间:
1994-07
期刊:
The Journal of pharmacology and experimental therapeutics
影响因子:
--
作者:
T. Shimada;H. Yamazaki;M. Mimura;Y. Inui;F. Guengerich
通讯作者:
T. Shimada;H. Yamazaki;M. Mimura;Y. Inui;F. Guengerich
DOI:
10.1097/00008571-200110000-00006
发表时间:
2001-10-01
期刊:
PHARMACOGENETICS
影响因子:
--
作者:
Dai, D;Zeldin, DC;Goldstein, JA
通讯作者:
Goldstein, JA
DOI:
--
发表时间:
1997
期刊:
Cancer research.
影响因子:
--
作者:
Dehal,SS;Kupfer,D
通讯作者:
Kupfer,D
DOI:
10.1097/00008571-200107000-00008
发表时间:
2001-07-01
期刊:
PHARMACOGENETICS
影响因子:
--
作者:
Eiselt, R;Domanski, TL;Wojnowski, L
通讯作者:
Wojnowski, L
DOI:
--
发表时间:
2000-04
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
JoAnn Hirth;P. Watkins;Myla H. Strawderman;A. Schott;R. Bruno;L. Baker
通讯作者:
JoAnn Hirth;P. Watkins;Myla H. Strawderman;A. Schott;R. Bruno;L. Baker